Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer.
Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been shown to be useful in the diagnosis and staging of a variety of malignancies. Because of its high sensitivity, FDG PET frequently detects malignant lesions that are not demonstrated clearly by anatomic imaging modalities. FDG PET usually has high negative predictive value and, therefore, negative studies are highly suggestive of a benign process. The authors present a patient in whom transesophageal echocardiography and magnetic resonance imaging described pericardial metastasis from a recurrent lung cancer, which on FDG PET was shown correctly to suggest benign scar tissue.
Ghesani
Nasrin V
NV
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA. alavi@oasis.rad.upenn.edu
Sun
Xinhui
X
Zhuang
Hongming
H
Sam
Joseph W
JW
Alavi
Abass
A
D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000556:secondary; D002921:Cicatrix / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D004452:Echocardiography; D004719:Endomyocardial Fibrosis / Q000000981:diagnostic imaging*; D005189:False Positive Reactions; D019788:Fluorodeoxyglucose F18; D006321:Heart / Q000000981:diagnostic imaging; D006338:Heart Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000556:secondary; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18